Aclaris Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $114k | 109k | 1.05 |
| 2023-09-30 | $890k | 130k | 6.85 |
| 2023-06-30 | $508k | 49k | 10.37 |
| 2023-03-31 | $385k | 48k | 8.11 |
| 2022-12-31 | $736k | 47k | 15.76 |
| 2022-03-31 | $544k | 32k | 17.23 |
| 2021-12-31 | $470k | 32k | 14.53 |
| 2021-09-30 | $589k | 33k | 17.99 |
| 2021-06-30 | $737k | 42k | 17.56 |
| 2021-03-31 | $734k | 29k | 25.21 |
| 2019-09-30 | $34k | 31k | 1.08 |
| 2019-06-30 | $68k | 31k | 2.18 |
| 2019-03-31 | $63k | 10k | 6.03 |
| 2017-06-30 | $11M | 408k | 27.12 |
| 2017-03-31 | $10M | 344k | 29.82 |